Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

782 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
TP53 signature predicts pathological complete response after neoadjuvant chemotherapy for breast cancer: Observational and confirmational study using prospective study cohorts.
Takahashi S, Sato N, Kaneko K, Masuda N, Kawai M, Hirakawa H, Nomizu T, Iwata H, Ueda A, Ishikawa T, Bando H, Inoue Y, Ueno T, Ohno S, Kubo M, Yamauchi H, Okamoto M, Tokunaga E, Kamigaki S, Aogi K, Komatsu H, Kitada M, Uemoto Y, Toyama T, Yamamoto Y, Yamashita T, Yanagawa T, Yamashita H, Matsumoto Y, Toi M, Miyashita M, Ishida T, Fujishima F, Sato S, Yamaguchi T, Takahashi F, Ishioka C. Takahashi S, et al. Among authors: hirakawa h. Transl Oncol. 2024 Oct;48:102060. doi: 10.1016/j.tranon.2024.102060. Epub 2024 Jul 24. Transl Oncol. 2024. PMID: 39047382 Free PMC article.
Minimal impact of postmastectomy radiation therapy on locoregional recurrence for breast cancer patients with 1 to 3 positive lymph nodes in the modern treatment era.
Miyashita M, Tada H, Suzuki A, Watanabe G, Hirakawa H, Amari M, Kakugawa Y, Kawai M, Furuta A, Sato K, Yoshida R, Ebata A, Sasano H, Jingu K, Ohuchi N, Ishida T. Miyashita M, et al. Among authors: hirakawa h. Surg Oncol. 2017 Jun;26(2):163-170. doi: 10.1016/j.suronc.2017.03.003. Epub 2017 Mar 16. Surg Oncol. 2017. PMID: 28577722
Tumor-infiltrating CD8+ and FOXP3+ lymphocytes in triple-negative breast cancer: its correlation with pathological complete response to neoadjuvant chemotherapy.
Miyashita M, Sasano H, Tamaki K, Chan M, Hirakawa H, Suzuki A, Tada H, Watanabe G, Nemoto N, Nakagawa S, Ishida T, Ohuchi N. Miyashita M, et al. Among authors: hirakawa h. Breast Cancer Res Treat. 2014 Dec;148(3):525-34. doi: 10.1007/s10549-014-3197-y. Epub 2014 Nov 14. Breast Cancer Res Treat. 2014. PMID: 25395319
Prognostic significance of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in residual tumors and alterations in these parameters after neoadjuvant chemotherapy in triple-negative breast cancer: a retrospective multicenter study.
Miyashita M, Sasano H, Tamaki K, Hirakawa H, Takahashi Y, Nakagawa S, Watanabe G, Tada H, Suzuki A, Ohuchi N, Ishida T. Miyashita M, et al. Among authors: hirakawa h. Breast Cancer Res. 2015 Sep 4;17(1):124. doi: 10.1186/s13058-015-0632-x. Breast Cancer Res. 2015. PMID: 26341640 Free PMC article.
An induction of microRNA, miR-7 through estrogen treatment in breast carcinoma.
Masuda M, Miki Y, Hata S, Takagi K, Sakurai M, Ono K, Suzuki K, Yang Y, Abe E, Hirakawa H, Ishida T, Suzuki T, Ohuchi N, Sasano H. Masuda M, et al. Among authors: hirakawa h. J Transl Med. 2012 Sep 19;10 Suppl 1(Suppl 1):S2. doi: 10.1186/1479-5876-10-s1-s2. J Transl Med. 2012. PMID: 23227519 Free PMC article.
Impact of Topoisomerase IIα, PTEN, ABCC1/MRP1, and KI67 on triple-negative breast cancer patients treated with neoadjuvant chemotherapy.
Guestini F, Ono K, Miyashita M, Ishida T, Ohuchi N, Nakagawa S, Hirakawa H, Tamaki K, Ohi Y, Rai Y, Sagara Y, Sasano H, McNamara KM. Guestini F, et al. Among authors: hirakawa h. Breast Cancer Res Treat. 2019 Jan;173(2):275-288. doi: 10.1007/s10549-018-4985-6. Epub 2018 Oct 10. Breast Cancer Res Treat. 2019. PMID: 30306430
782 results